Clinical Trials on Development, Human in Finland

Total 307 results

Helsinki University Central Hospital
University of Helsinki; Tampere University; Aalto University

Recruiting

Development of Motility and Cognition in Infants (PILKE)

Neurodevelopmental Disorders | Child Development | Developmental Delay | Development, Infant | Neurophysiologic Abnormality | Cognitive Developmental Delay

Finland
University of Helsinki
Karolinska Institutet; University of Turku; Folkhälsan Research Center; University... and other collaborators

Recruiting

Language Development Deficits and Early Interactive Music Intervention (BusyBaby)

Language Development Disorders | Language Development | Dyslexia, Developmental

Finland
New York State Institute for Basic Research
Boston Children's Hospital; Rutgers University

Recruiting

Vagus Nerve Stimulator for Autism and Other Developmental Disorders (VNS)

Intellectual Disability | Autism Spectrum Disorder | Developmental Disability | Autonomic Nervous System

United States
Helsinki University Central Hospital
University of Helsinki; Tampere University; Kamuzu University of Health Sciences

Recruiting

Assessment of Motor Development With a Wearable in Rural and Low-income Settings (MaMa)

Infant Development

Finland, Malawi
Natural Resources Institute Finland
Tampere University

Active, not recruiting

Biodiversity Interventions for Assisted Living Centers (BIWE)

Autism Spectrum Disorder | Microbial Colonization | Visual Impairment | Immune System and Related Disorders | Nature, Human | Well-Being, Psychological

Finland
Hospital for Children and Adolescents, Finland

Enrolling by invitation

A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

Kallmann Syndrome

Finland
University of Helsinki
Business Finland; Finnish Red Cross; Valio Ltd; DuPont Nutrition and Health; Oriola... and other collaborators

Unknown

Health and Early Life Microbiota (HELMi)

Overweight | Growth | Allergy | Infectious Disease | Child Development | Noncommunicable Diseases

Finland
Helsinki University Central Hospital
University of Helsinki; Finnish Institute for Health and Welfare; UKK Institute

Recruiting

Factors Affecting Newborn Body Composition and Later Health in Helsinki Birth Cohort 2018-2022 (HeBiCo)

Pregnancy Related | Obesity, Childhood | Child Development | Lifestyle | Offspring, Adult

Finland
Turku University Hospital
University of Turku

Completed

Nutrition and Pregnancy Intervention Study

Liver Diseases | Obesity | Pregnancy | Neurodevelopmental Disorders | Type2 Diabetes | Adiposity | Cardiovascular Risk Factor | Gestational Diabetes Mellitus | Eating Behavior | Cognitive Developmental Disorders

Finland
Nestlé

Completed

Infant Nutrition and Brain Development

Healthy | Infant Development

United States
Social Insurance Institution, Finland
Turku University Hospital; University of Turku

Completed

A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric Disorders

ADHD | Asperger Syndrome | Child Behavior Disorders

Finland
Turku University Hospital

Unknown

Serum Biomarker HE4 During IVF Treatment (FHE4)

IVF Treatment | Human Epididymal Secretory Protein E4

Finland
Natural Resources Institute Finland
Tampere University

Active, not recruiting

Biodiversity Interventions for Well-Being (BIWE)

Immune System Diseases | Microbial Colonization | Nature, Human | Well-Being, Psychological

Finland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM

Influenza

Finland
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Influenza

Finland
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers

Influenza

Finland
Finnish Institute for Health and Welfare
Hospital District of Helsinki and Uusimaa

Recruiting

Immune Responses in Health Care Personnel

Influenza

Finland
Finnish Institute for Health and Welfare
RWTH Aachen University; University of Erfurt

Completed

Herd Immunity and Influenza Vaccine Uptake (HIIVU)

Influenza, Human

Finland
MedImmune LLC

Completed

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

Influenza

Finland
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Influenza

Finland
Turku University Hospital
University of Turku; University of Helsinki

Recruiting

Evaluation of Digital Follow up of Preterm Infants (ePIPARI)

Preterm Birth | Growth Disorders | Sensory Disorder | Family Relations | Development Delay

Finland
Novartis Vaccines

Completed

Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study

FLU

Finland
SYNOSTE Oy
Technical University of Munich; MVZ Labor Dr. Limbach

Terminated

SYNOSTE Nitinail System Trial

Leg Length Inequality

Finland, Turkey
Sanofi Pasteur, a Sanofi Company

Terminated

Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older

Influenza (Healthy Volunteers)

Finland
Hospital District of Southwestern Finland
Hoffmann-La Roche

Completed

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age (ETOPOM)

Influenza

Finland
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Prophylaxis of Avian Influenza

Finland
Finnish Institute for Health and Welfare

Completed

Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11

Influenza Caused by the 2009 H1N1 Influenza Virus

Finland
Women and Infants Hospital of Rhode Island

Completed

NICU Parent Education Program (NICU PEP)

Premature Infant | Language Development | Neurodevelopmental Outcomes

United States
Women and Infants Hospital of Rhode Island

Unknown

A Language Intervention Study of Preterm Infants

Maternal Behavior | Language Development | Mother-Infant Interaction | Language Delay

United States
Finnish Institute for Health and Welfare

Completed

Evaluation of Pandemic Vaccination Campaign

Influenza Caused by the Novel A(H1N1)v Influenza Virus

Finland
Novartis
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

Pandemic Influenza Disease

Finland, Germany
Sanofi

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Influenza Immunization (Healthy Volunteers)

Finland, Germany
University of Oulu

Active, not recruiting

Sequelae of Developmental Dysplasia of the Hip

Hip Dysplasia | Developmental Dysplasia of the Hip

Finland
Helsinki University Central Hospital

Completed

Diagnosing Adult Growth Hormone Deficiency

Growth Hormone Deficiency

Finland
Ology Bioservices

Completed

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Influenza | Avian Influenza

Austria, Finland
Helsinki University Central Hospital

Unknown

PCV13 + Hepatitis A Vaccine for Adults (PCV13+HepA)

Measurement of Immune Response to Prevenar13 | Measurement of Immune Response to Hepatitis A

Finland, Sweden
University of Rhode Island
Women and Infants Hospital of Rhode Island

Completed

18 Month Follow Up of Preterm Infants Enrolled in the Cord Clamping Study (18mo)

Developmental Delay

United States
University of Helsinki

Completed

Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis

Alcoholic Hepatitis | Alcoholic Cirrhosis

Finland
Natural Resources Institute Finland
Tampere University

Recruiting

Nationwide Research on the Rewilding of Kindergarten Yards (Vahvistu)

Allergy | Cognitive Change | Microbial Colonization | Asthma in Children | Atopic Dermatitis | Respiratory Infection | Nature, Human

Finland
Lars Rombo

Completed

Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Response to Hepatitis A Vaccine

Finland, Sweden
Natural Resources Institute Finland
Tampere University

Recruiting

Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis (BIWE)

Microbial Colonization | Atopic Dermatitis | Immune System and Related Disorders | Nature, Human

Finland
National Cancer Institute (NCI)

Not yet recruiting

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Human Papillomavirus-Related Carcinoma

United States, Austria
Hoffmann-La Roche

Terminated

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Spectrum Disorder

Autism Spectrum Disorder

United States
Rhode Island Hospital
Bradley Hospital; Nancy Lurie Marks Family Foundation

Completed

Transcranial Magnetic Stimulation Studies in Autism Spectrum Disorders

Intellectual Disability | Autism Spectrum Disorder

United States
Brown University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Active, not recruiting

Game Plan for PrEP

Alcohol; Harmful Use | Human Immunodeficiency Virus Exposure

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

Influenza | Orthomyxoviridae Infections | Orthomyxovirus Infections

Finland
Ipsen

Completed

Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq (OPTIMA)

Renal Insufficiency, Chronic | Pituitary Diseases | Dwarfism | Turner Syndrome

France, Germany, Finland, Spain, Belgium, Czechia, Denmark, Greece, Italy, Romania, Russian Federation, Slovakia, Ukraine, United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months

Influenza | Swine-origin A/H1N1 Influenza

Finland
GlaxoSmithKline

Completed

A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults

Influenza

Finland, Czech Republic
Sanofi Pasteur, a Sanofi Company

Completed

A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

Influenza | Swine-origin A/H1N1 Influenza

Finland

Clinical Trials on Development, Human in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations